Peripheral Blood Plasma Clot as a Local Antimicrobial Drug Delivery Matrix

Jan Gessmann1,2, Dominik Seybold1,2, Fahim Ayami2

  • 11 Department of Trauma Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum , Bochum, Germany .

Insights

Autologous plasma clots effectively deliver vancomycin and gentamicin antibiotics, maintaining antibacterial activity for days without harming human mesenchymal stem cells (hMSC). Silver ions also showed antimicrobial effects but were cytotoxic to hMSC.

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Tissue Engineering

Background:

  • Autologous plasma clots offer a potential scaffold for localized drug delivery.
  • Effective antimicrobial strategies are crucial for preventing implant-associated infections.
  • Biocompatible drug delivery systems are needed to support tissue regeneration.

Purpose of the Study:

  • To evaluate the release kinetics and antimicrobial efficacy of antibiotics (vancomycin, gentamicin, linezolid) and silver ions loaded into autologous plasma clots.
  • To assess the impact of these agents on fibrin fiber structure and the biocompatibility with human mesenchymal stem cells (hMSC).
  • To determine the duration of antibacterial activity and potential cytotoxicity of the loaded plasma clots.

Main Methods:

  • Plasma clots were loaded with vancomycin, gentamicin, linezolid, or silver acetate at varying concentrations.
  • Drug and silver ion release was quantified using RP-HPLC and AAS, respectively.
  • Antimicrobial activity against Staphylococcus aureus and cytotoxicity on hMSC were assessed. Fibrin structure was analyzed via SEM.

Main Results:

  • Vancomycin and gentamicin showed sustained release up to 7 days, while linezolid release was limited to 4 hours.
  • Gentamicin and silver ions increased fibrin fiber thickness; linezolid and vancomycin did not.
  • Antibiotic-loaded clots demonstrated concentration-dependent antimicrobial activity and were non-cytotoxic to hMSC, whereas silver ions exhibited cytotoxicity.

Conclusions:

  • Autologous plasma clots serve as effective carriers for sustained delivery of vancomycin and gentamicin.
  • These antibiotic-loaded clots maintain antibacterial efficacy for days without adverse effects on embedded hMSC.
  • Silver ions show antimicrobial potential but pose a risk of cytotoxicity, limiting their use in combination with stem cells.

Related Concept Videos

Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
4.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.4K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
9.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.8K